Genetic Testing Before Serologic Screening in Relatives of Patients With Celiac Disease as a Cost Containment Method

Abstract

Repeat screening of relatives with celiac disease results in a significant increase in cost, but also an associated increase in cases diagnosed. Genetic testing would potentially eliminate up to 60% of the population to be screened and, if available at a lower cost, would partially offset costs of repeat serologic screening.